Elicio
1 known investors
Elicio develops cancer immunotherapies including vaccines, immunomodulators, and adjuvants built on its lymph node-targeted AMP platform to activate and amplify cancer-fighting T cells. The company focuses on treating solid tumors, particularly pancreatic ductal adenocarcinoma (PDAC).
BiotechHealthtech
Investors Β· 1
Frequently asked questions
- What does Elicio do?
- Elicio develops cancer immunotherapies including vaccines, immunomodulators, and adjuvants built on its lymph node-targeted AMP platform to activate and amplify cancer-fighting T cells. The company focuses on treating solid tumors, particularly pancreatic ductal adenocarcinoma (PDAC).
- Who are Elicio's investors?
- Elicio's investors include Clal Biotechnology Industries.